PMLS Virtual Series 2021 – Precision Oncology Spring

On Demand Now Click Here

March 30, 2021

Nelson Alexander, PhD

Research Leader, Roche Sequencing Solutions

Steve Anderson, PhD

Chief Science Officer, Covance; Senior Vice President, LabCorp Drug Development

R. Michael Barlow

Senior Advisor, ADVI

Suzanne Belinson, PhD, MPH

Vice President, Commercial Markets, Tempus

Adrian Bot, MD, PhD

Vice President, Translational Medicine, Kite, a Gilead Company

Lisa H. Butterfield, PhD

Vice President, PICI Research and Development, Parker Institute for Cancer Immunotherapy, Adjunct Professor, Microbiology and Immunology, University California San Francisco

Alessandra Cesano, MD, PhD

Chief Medical Officer, ESSA

Jim Christian, MD

Pathologist, Companion Diagnostics, Agilent Technologies

Radu Dobrin, PhD

Executive Director, Head of Bioinformatics Immunology and Immuno-Oncology, Thematic Research Center, Bristol Myers Squibb; Adjunct Associate Professor, Icahn School of Medicine, Mount Sinai School of Medicine

Joel Dudley, PhD, MS

Chief Scientific Officer, Tempus